19 Reasons to drink GoChi™ Every Day!
With Scientifically Demonstrated Results, There’s No Excuse Not To!
On January 8, 2008, FreeLife released a groundbreaking study which was accepted for publication by the highly respected Journal of Alternative and Complementary Medicine (JACM). As a peer-reviewed journal, JACM will only publish research that has been independently verified by an expert panel of judges, and that level of scientific validation truly represents a first for a juice product in our industry.
This pivotal randomized, double-blind and placebo-controlled human clinical trial showed that a daily serving of just 4 ounces of GoChi can significantly improve your health and well-being in 13 important ways in just 14 days!
And subsequent studies have demonstrated how drinking 4 ounces of GoChi on a daily basis can deliver 6 more benefits, increasing your body’s antioxidant power and significantly enhancing vital immune defenses in just 30 days!
The 19 benefits identified in FreeLife’s three GoChi studies are no coincidence. They are all interrelated, and have been collectively termed The GoChi Effect™.
The first 14-day study was conducted to examine the potential short-term benefits of GoChi on 13 key aspects of health and well-being. Thirty-five test subjects were divided at random into two groups. The first group received 4 oz daily of GoChi. The second group received 4 oz daily of a placebo (a similar-tasting juice that did not contain any LBP, the active ingredient of GoChi). The GoChi group experienced significantly better results than the placebo group in all 13 categories. Since the study was double-blind, neither FreeLife’s scientists who conducted the study, nor its employees, who served as the study’s participants, knew if they were drinking the real GoChi or the inactive placebo.
The second study, conducted by a prestigious medical center in Asia, was a 30-day investigation into antioxidant activity in the human body. Fifty healthy adult volunteer test subjects were divided at random into two groups—a GoChi group and a placebo group. Each group received a 4 oz daily serving of either GoChi or an inactive placebo respectively. None of the test subjects were associated with FreeLife® nor had they consumed Himalayan Goji® Juice or GoChi prior to the study. After 30 days, the GoChi group showed significant improvement in antioxidant activity, as evidenced by significant increases over starting point values in blood levels of the important antioxidant enzymes superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px). Also found in the GoChi group was a significant decrease in levels of toxic malondialdehyde (MDA), a key blood marker of oxidative stress, free-radical damage, and premature cell aging. No significant differences were observed in the placebo group in these areas.
The third study, also conducted by a renowned Asian medical center, examined the 30-day effects of GoChi on the immune system. Sixty healthy adult volunteer test subjects were divided at random into two groups—a GoChi group and a placebo group. Each group received a 4 oz daily serving of either GoChi or an inactive placebo, respectively. None of the test subjects were associated with FreeLife nor had they consumed Himalayan Goji Juice or GoChi prior to the study. After 30 days, the GoChi group showed significant improvement over starting point values in the following three immune blood markers: (i) lymphocytes (white blood cells necessary for immune defenses); (ii) interleukin 2 (IL-2), an important cell-signaling molecule; and (iii) immunoglobulin G (IgG), a powerful antibody. Also noted in the GoChi group were health and well-being improvements that had been seen in prior studies: significant improvement in sleep quality, reduction of fatigue, and a tendency for increased short-term memory and mental focus. No significant improvements were observed in the placebo group in any category.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.